SHERIDAN, WYOMING - April 04, 2026 - Dental diagnostic practice faces a structural shift as the first commercially positioned dental-dedicated MRI (ddMRI) clears FDA review, enabling clinicians to visualize soft tissue, nerves, cartilage, and active inflammation without ionizing radiation - capabilities no CBCT or conventional X-ray system can match. The MAGNETOM Free.Max Dental Edition, developed by Dentsply Sirona in collaboration with Siemens Healthineers, now holds FDA clearance following validation in a clinical trial, placing radiation-free soft tissue diagnostics within reach of in-clinic dental settings for the first time.
What the MAGNETOM Free.Max Dental Edition delivers
The system operates at a 0.55T field strength and is engineered specifically for dental anatomy rather than adapted from general-purpose radiology hardware. A dental-dedicated coil maximizes detectable imaging signal across dentomaxillofacial structures while maintaining an open, flexible design to balance image quality against patient comfort. The accompanying software uses artificial intelligence to automatically recognize landmarks and align the field of view to relevant oral and maxillofacial regions, removing the manual setup steps that make standard MRI impractical in a dental office environment.
Scan protocols are designed to match the operational tempo of a dental practice: the full workflow - including setup, scanning, and cleaning - completes in 20 minutes or less for all supported clinical indications. Initial clinical indications include periodontitis assessment, endodontic evaluation, temporomandibular joint (TMJ) imaging, pre-extraction nerve mapping for third molar procedures, and orthodontic cephalometric analysis. In tooth extraction workflows, ddMRI can visualize the lingual nerve relative to a third molar - an anatomical relationship CBCT cannot resolve - directly reducing surgical risk.
Infrastructure requirements and siting constraints
One of the practical barriers to in-clinic MRI has been facility infrastructure. The MAGNETOM Free.Max addresses this through a sealed-for-life DryCool technology that eliminates the need for a quench pipe, removing the major construction commitment that conventional superconducting MRI systems require. The unit stands under 2 meters in height, weighs less than 3.2 tonnes, and fits within a 24 square meter room - dimensions compatible with existing dental clinic floor plans and accessible through standard doorways.
The low weight also opens installation on upper floors of multi-story buildings, which is prohibited for most MRI systems. Combined with the absence of quench pipe infrastructure, these specifications reduce both capital installation costs and the lead time from purchase decision to first clinical scan. Dental practices can integrate the system without contracting radiology departments or referring patients off-site, which compresses the diagnostic cycle and keeps imaging revenue within the practice.
Clinical evidence base and diagnostic differentiation
Published clinical research cited by Dentsply Sirona - including a 2023 study by Greiser et al. in Dentomaxillofacial Radiology - establishes technical specifications and feasibility of the ddMRI approach. The system's ability to distinguish active inflammation from resolved lesions represents a direct complement to CBCT: conventional cone beam imaging shows bone structure with high resolution but provides no information on lesion activity status, whereas ddMRI's inflammation protocol visualizes active inflammation in the surrounding soft tissue. For periodontics, ddMRI depicts periodontal structures alongside bone level data and the presence of edema within bone - a composite view not achievable from a single CBCT acquisition.
The non-ionizing radiation profile carries specific clinical value for pediatric patients and for adults requiring serial monitoring, such as implant follow-up or tracking disease progression over time. Regular preventive screening becomes feasible without cumulative radiation exposure, which aligns with an emerging preventive care model linking oral health indicators to systemic conditions including diabetes and cardiovascular disease.
Business impact
Procurement leads and practice owners evaluating capital imaging equipment in 2026 face a defined decision point: whether ddMRI justifies placement alongside or ahead of CBCT refresh cycles. FDA clearance converts the technology from research-stage to a purchasable, reimbursable-pathway-eligible device, making it a legitimate line item in 2026-2027 equipment budgets. The sub-24 m² footprint and self-contained infrastructure profile mean that space planning and construction costs - previously prohibitive for most multi-chair dental practices - no longer block adoption.
Dental group operators and DSO (dental service organization) procurement teams must now evaluate whether centralized ddMRI placement across a network or per-location deployment better serves diagnostic throughput targets. The 20-minute scan cycle and automated protocols reduce the per-scan labor requirement, making high-volume use operationally viable without hiring dedicated MRI technologists. For oral and maxillofacial surgeons and specialist periodontists, the nerve visualization and soft tissue pathology capabilities directly expand the diagnostic billable service set. Technology roadmap decisions in diagnostic imaging must now account for a validated, cleared ddMRI option from an established dental industry supplier.